World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
22598
World Ranking
15725
National Ranking
7915

Overview

Luka Milas is affiliated with The University of Texas MD Anderson Cancer Center in the United States. This association situates them within a leading institution known for cancer research and treatment. Their scientific work is connected to this environment, which often focuses on oncological and biomedical studies.

There are no recent papers or specific publication titles available for Luka Milas. Consequently, detailed information about the scope and content of their research articles cannot be provided.

No information is available on frequent co-authors, indicating either independent work or a lack of publicly recorded collaborative patterns in the accessible data.

The data also does not list any frequent publication venues, so it is not possible to specify the journals or conferences where Luka Milas tends to publish scientific findings.

Similarly, there are no recorded book publications, which suggests that the scientist has not contributed to academic books in a manner documented in the source data.

Details about Luka Milas' main fields of study, subfields, and research topics are absent. Without this, it is not possible to outline their exact scientific specialties or the thematic areas of their work.

No awards or honors are recorded in the data. This implies that no specific recognitions have been noted or indexed within the available records.

Luka Milas is currently living, which allows for the possibility of ongoing research activities and contributions in their field.

Best Publications

  • Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

    K. Kian Ang;Brian A. Berkey;Xiaoyu Tu;Hua Zhong Zhang

  • Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

    Klaus Dittmann;Claus Mayer;Birgit Fehrenbacher;Martin Schaller

  • In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

    Luka Milas;Kathy Mason;Nancy Hunter;Sven Petersen

  • Complete Regression of Well-established Tumors Using a Novel Water-soluble Poly(l-Glutamic Acid)-Paclitaxel Conjugate

    Chun Li;Dong Fang Yu;Robert A. Newman;Fernando Cabral

  • Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas

    Tetsuo Akimoto;Nancy R. Hunter;Lara Buchmiller;Kathy Mason

  • The epidermal growth factor receptor mediates radioresistance.

    Ke Liang;K.Kian Ang;Luka Milas;Nancy Hunter

  • Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.

    Kazushi Kishi;Sven Petersen;Cordula Petersen;Nancy Hunter

  • Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme

    Luka Milas;Kazushi Kishi;Nancy Hunter;Kathryn Mason

  • Sensitization of breast cancer cells to radiation by trastuzumab.

    Ke Liang;Yang Lu;Weidong Jin;K. Kian Ang

  • Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.

    R. E. Meyn;L. C. Stephens;Kie-Kian Ang;N. R. Hunter

  • Apoptosis in irradiated murine tumors.

    L. C. Stephens;K. K. Ang;T. E. Schultheiss;L. Milas

  • Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.

    Cordula Petersen;Sven Petersen;Luka Milas;Frederick F. Lang

  • Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.

    Luka Milas;Nancy R. Hunter;Belma Kurdoglu;Kathryn A. Mason

  • Tissue tolerance to reirradiation

    Carsten Nieder;Luka Milas;K. Kian Ang

  • Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

    Christopher Crane;James L. Abbruzzese;Douglas B. Evans;Robert A Wolff

  • Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?

    Hak Choy;Luka Milas

  • Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.

    Luka Milas;Zhen Fan;Nicolaus H. Andratschke;K.Kian Ang

  • Enhancement of tumor radioresponse in vivo by gemcitabine

    Luka Milas;Takashi Fujii;Takashi Fujii;Nancy Hunter;Mohamed Elshaikh

  • Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: report of a randomized comparative trial

    Ritsuko Komaki;Jin Soo Lee;Luka Milas;Hoon K. Lee

  • Single Nucleotide Polymorphism at rs1982073:T869C of the TGFβ1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Definitive Radiotherapy

    Xianglin Yuan;Zhongxing Liao;Zhensheng Liu;Li E. Wang

Frequent Co-Authors

K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Raymond E. Meyn
Raymond E. Meyn The University of Texas MD Anderson Cancer Center
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Sidney Wallace
Sidney Wallace The University of Texas MD Anderson Cancer Center
Walter N. Hittelman
Walter N. Hittelman The University of Texas MD Anderson Cancer Center
Lester J. Peters
Lester J. Peters Peter MacCallum Cancer Centre
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn’t always mean pursuing the traditional MD path. In fact, healthcare offers a wide range of online degrees and flexible career options to fit diverse goals and backgrounds.

For registered nurses, advancing your education with a BSN can be both convenient and affordable. Learn more about the average cost of rn to bsn programs to discover cost-effective ways to expand your qualifications.

If you don’t have a nursing background but want to quickly enter advanced nursing roles, consider the growing number of msn direct entry programs online. These accelerated programs are designed especially for non-nursing graduates seeking a fast track into the nursing profession.

Those new to healthcare might start with the adn programs, which provide a shorter and often more accessible path to becoming a registered nurse.

Alternatively, if you’re interested in the administrative side of healthcare, there are excellent options for medical billing and coding online schools that accept financial aid, opening the door to remote career opportunities without patient care duties.

Best Scientists Citing Luka Milas